Studies are conducted to better define the mechanisms involved in tumor growth and spread (i.e. metastases). Most human tumors cannot be studied in vitro because they grow poorly in culture and in nude mice (less than 5% grow). Previously we found that tumor cells grow well in vitro when exposed to a basement membrane substratum. When tumor cells are premixed with a basement membrane mixture (matrigel) and injected subcutaneously, rapid growth of all tumors studied to date is observed. Tumor metastasis requires that the cells adhere to the vessel basement membrane, degrade it and migrate through. Laminin is a potent inducer of collagenase, and we find that a synthetic peptide from laminin of 18 amino acids promotes collagenase IV activity and tumor metastases. It is active even when injected intravenously several hours after the tumor cells are injected. In the Matrigel subcutaneous model, tumor growth is accelerated by the peptide two-fold. This peptide also induces collagenase IV activity in non malignant cells and makes them have an invasive phenotype. Likewise, transfection of tumor cells with this enzyme results in increased tumor spread. Our goal is to better understand the malignant phenotype to devise diagnostic and therapeutic strategies to reduce tumor growth and spread.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Intramural Research (Z01)
Project #
1Z01DE000482-03
Application #
3854226
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Name
National Institute of Dental & Craniofacial Research
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Campo McKnight, Dianalee A; Sosnoski, Donna M; Koblinski, Jennifer E et al. (2006) Roles of osteonectin in the migration of breast cancer cells into bone. J Cell Biochem 97:288-302
Koblinski, Jennifer E; Kaplan-Singer, Benjamin R; VanOsdol, Sherilyn J et al. (2005) Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis. Cancer Res 65:7370-7
Huh, Jung-Im; Calvo, Alfonso; Stafford, Jeffrey et al. (2005) Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms. Oncogene 24:790-800
Lugassy, Claire; Kleinman, Hynda K; Engbring, Jean A et al. (2004) Pericyte-like location of GFP-tagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis. Am J Pathol 164:1191-8
Munshi, Hidayatullah G; Wu, Yi I; Mukhopadhyay, Subhendu et al. (2004) Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J Biol Chem 279:39042-50
Hibino, Suguru; Shibuya, Masahiko; Engbring, Jean A et al. (2004) Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy. Cancer Res 64:4810-6
Bos, T J; Cohn, S L; Kleinman, H K et al. (2004) International Hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions. Matrix Biol 23:63-9
Elkin, Michael; Orgel, Adam; Kleinman, Hynda K (2004) An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1. J Natl Cancer Inst 96:875-8
Elkin, Michael; Cohen, Irit; Zcharia, Eyal et al. (2003) Regulation of heparanase gene expression by estrogen in breast cancer. Cancer Res 63:8821-6
Cha, Hee-Jae; Jeong, Moon-Jin; Kleinman, Hynda K (2003) Role of thymosin beta4 in tumor metastasis and angiogenesis. J Natl Cancer Inst 95:1674-80

Showing the most recent 10 out of 12 publications